Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Jan 18, 2023 5:09pm
338 Views
Post# 35231765

RE:Accelerated Approval ahead of AUA congress would spark

RE:Accelerated Approval ahead of AUA congress would spark ScienceFirst wrote:

"Accelerated Approval, instead of Breakthrough Therapy, ahead of AUA congress, would clearly spark interest and curiosity as it would mean that urologists could then immediately prescribe our treatment to patients that are not even in our Ph. 2 trial."

And possibly even for other cancer indications. Roswell Park, for example, treats gynecologic malignancies, head & neck cancer and dysplasia and skin cancers with PDT off-label.

Diseases We Treat With PDT at Roswell Park

CancerSlayer's post from January 15 is especially relevant here as he posted a long list of centre's where photodynamic therapy is currently being provided:

https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=35224503

"....... I could also see medical providers using our ACT/drug (in lieu of Photofrin, etc.) for other/similar cancers...such off-label use is considered acceptable & can be an alternative option for more resistant/severe cases.   All of the above imo.

If all goes well with this trial, I can see a fairly rapid ramp-up of our ACT in the oncology-solid tumor field.   There is an extensive list of reputable PDT centers in the U.S. & they have no/little choice but to use an outdated/older generation PS like Photofrin.  In addition to our trial sites, here is a list of some reputable centers in the U.S. that could adopt our more effective/patient-friendly PS.
 

Photodynamic Therapy Center of Roswell Park Cancer Institute
Buffalo, New York RPCI’s Photodynamic Therapy Center offers PDT for lung, gynecologic, esophageal, oral, skin, head and neck cancers, as well as Barrett’s esophagus and other precancerous conditions or lesions.

Mayo Clinic Hospital Rochester, Minnesota (plus 6 satellite clinics in FL, AR, MN) The Mayo Clinic offers PDT for lung cancer, esophageal cancer, Barrett’s esophagus, stomach cancer, bladder cancer and bile duct tumors.

Cancer Treatment Centers of America Boca Raton, Florida (new central office) CTCA offers PDT for lung cancer, esophageal cancer and inoperable bile duct tumors.

MD Anderson Cancer Center Houston, Texas PDT is offered as a treatment option for lung cancer and esophageal cancer.

Dana Farber Cancer Institute Boston, Massachusetts (at five different locations) Photodynamic therapy has been approved for the treatment of patients with non-small cell lung cancer (central or endobronchial), esophageal cancer, basal cell carcinoma, and precancerous skin conditions.

Duke Cancer Institute Durham, North Carolina At Duke Cancer Institute, PDT is currently being used to treat esophageal cancer, non-small cell lung cancers, mesothelioma, and some skin cancers.

Fox Chase Cancer Center Buckingham, Pennsylvania Fox Chase offers photodynamic therapy (PDT) for the treatment of lung cancer as well as for  obstructing tumors of the esophagus, severe dysplasia with Barrett’s esophagus, and early, localized gastric carcinoma.

Huntsman Cancer Institute/University of Utah Health Care Salt Lake City, Utah PDT is offered at this hospital for the treatment of esophageal cancer and endobronchial tumors (central lung cancer, tumors located in the airways).

Penn Medicine Hospitals Philadelphia, Pennsylvania (including 5 Hospitals) PDT is offered at Penn Medicine hospitals for lung cancer, head and neck cancer, and gastrointestinal tumors such as esophageal and gastric tumors. 

Boston Medical Center Boston, Massachusetts The Boston Medical Center is offering PDT for Barrett’s esophagus and as a palliative treatment for esophageal cancer.

Cleveland Clinic Cleveland, Ohio Cleveland Clinic offers PDT for Barrett’s esophagus, bile duct tumors, and bladder cancer.

UW Carbonne Cancer Center Madison, Wisconsin Photodynamic therapy is offered here for central lung cancer and esophageal cancer.

Lakewood Ranch Medical Center Bradenton, Florida PDT is used at this Center for the treatment and palliation of esophageal, pulmonary and bladder malignancies.

UC San Diego Health System San Diego, California PDT is used at this clinic for the treatment of endobronchial tumors (central lung cancer, tumors located in the airways).

Puget Sound Gastroenterology/Seattle Gastroenterology Associates Seattle, Washington It appears that Dr. Bohorfoush offers PDT for Barrett’s esophagus and possibly early-stage esophageal cancer and bile duct tumors.

San Diego Interventional Procedures & Complex Airway Center San Diego, California This Center may offer PDT for central lung cancer (endobronchial carcinoma).

Kaiser Gornick LLP San Francisco, California This clinic offers PDT for Mesothelioma.

 

Valley Hospital,  Blumenthal Cancer Center Paramus, New Jersey This center offers PDT for Barrett’s Esophagus.

HCA West Florida Tampa, Florida (16 affiliated hospitals) This clinic appears to provide PDT for bladder cancer.

Virginia Mason Hospital Seattle, Washington PDT is provided at this clinic for Barrett’s Esophagus.

Well Pacific Cancer Foundation Bellevue, Washington This Center specializes in PDT for brain tumors.

Gastrointestinal Associates (GIA), P.C. Knoxville, Tennessee Dr. Bergein Overholt specializes in photodynamic treatment of Barrett’s Esophagus and possible early-stage esophageal cancer.

Children’s Hospital of Wisconsin Milwaukee, Wisconsin Dr. Harry T. Whelan specializes in the photodynamic treatment of brain tumors; he is currently overseeing a clinical trial of PDT for recurrent high-grade gliomas.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland PDT is offered for central lung cancer (small endobronchial tumors), Barrett’s esophagus, esophageal cancer, and some skin cancers.

Moffitt Cancer Center Tampa, Florida This center offers PDT for esophageal cancer, central lung cancer (endobronchial tumors) and other tumors.

The Ohio State University Comprehensive Cancer Center Columbus, Ohio   (2 hospitals, including James Cancer Hospital) Ohio State’s photodynamic program offers PDT for curative, palliative and combined modality treatments of lung cancer.

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine St. Louis, Missouri This center offers PDT for central lung cancer (endobronchial tumors) and possibly some esophageal tumors.

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan This center offers PDT for central lung cancer (endobronchial tumors) and esophageal cancer, as well as possibly other cancers.

Vanderbilt-Ingram Cancer Center Nashville, Tennessee This center offers PDT for central lung cancer (endobronchial tumors) and esophageal cancer."


<< Previous
Bullboard Posts
Next >>